Stanley Xu to Angiotensin-Converting Enzyme Inhibitors
This is a "connection" page, showing publications Stanley Xu has written about Angiotensin-Converting Enzyme Inhibitors.
Connection Strength
1.117
-
Risk of Breast Cancer With Long-Term Use of Calcium Channel Blockers or Angiotensin-Converting Enzyme Inhibitors Among Older Women. Am J Epidemiol. 2017 02 15; 185(4):264-273.
Score: 0.538
-
Increasingly restrictive definitions of hyperkalemia outcomes in a database study: effect on incidence estimates. Pharmacoepidemiol Drug Saf. 2010 Jan; 19(1):19-25.
Score: 0.328
-
The positive predictive value of a hyperkalemia diagnosis in automated health care data. Pharmacoepidemiol Drug Saf. 2010 Nov; 19(11):1204-8.
Score: 0.087
-
Diabetes and drug-associated hyperkalemia: effect of potassium monitoring. J Gen Intern Med. 2010 Apr; 25(4):326-33.
Score: 0.082
-
Use of stabilized inverse propensity scores as weights to directly estimate relative risk and its confidence intervals. Value Health. 2010 Mar-Apr; 13(2):273-7.
Score: 0.081